$SRPT

$18.89 +$0.91 (5.06%) Close

$SRPT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$SRPT Management Team

Dr. M. Kathleen Behrens

Independent Chairwoman of the Board

Age 72

Compensation $617.0K USD

Sex Female

Mr. Ian Estepan

President

Chief Operating Officer

Age 49

Compensation $2.753M USD

Sex Male

Mr. Douglas Ingram

Chief Executive Officer

Age 62

Compensation $1.978M USD

Sex Male

Mr. Ryan Wong

Chief Financial Officer

Executive Vice President

Age 46

Compensation -

Sex Male

Dr. Louise Rodino-Klapac

President - Research and Development and Technical Operations

Age 47

Compensation $2.737M USD

Sex Female

Ms. Cristin Rothfuss

Executive Vice President

General Counsel

Corporate Secretary

Age 57

Compensation -

Sex Female

Mr. Dallan Murray

Executive Vice President

Chief Customer Officer

Age 55

Compensation $2.666M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. M. Kathleen Behrens Independent Chairwoman of the Board	72	$617.0K USD	Female
Mr. Ian Estepan President Chief Operating Officer	49	$2.753M USD	Male
Mr. Douglas Ingram Chief Executive Officer	62	$1.978M USD	Male
Mr. Ryan Wong Chief Financial Officer Executive Vice President	46	-	Male
Dr. Louise Rodino-Klapac President - Research and Development and Technical Operations	47	$2.737M USD	Female
Ms. Cristin Rothfuss Executive Vice President General Counsel Corporate Secretary	57	-	Female
Mr. Dallan Murray Executive Vice President Chief Customer Officer	55	$2.666M USD	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

8.8 years

from year joined

CEO also chairs the board

M. Kathleen Behrens, Ph.D.

Director	Age	On board	Independent	Committees	Other public boards	Pay
Douglas S. Ingram CEO	63	2017 9 years	Not stated	None stated	Relay Therapeutics	Paid as CEO
Hans Wigzell, M.D., Ph.D.	87	2010 16 years	Not stated	Nominating and Corporate Governance Committee Research and Development Committee · Chair	RaySearch Laboratories AB	Not stated
Kathryn J. Boor, Ph.D.	67	2022 4 years	Not stated	Compensation Committee	Seneca Foods Corporation	Not stated
Michael Chambers	51	2022 4 years	Not stated	Research and Development Committee	Calviri Inc	Not stated
Deirdre Connelly	65	2024 2 years	Not stated	Compensation Committee · Chair Nominating and Corporate Governance Committee	Macy’s Corporation, Lincoln Financial Group, Genmab A/B	Not stated
Richard J. Barry	67	2015 11 years	Not stated	Nominating and Corporate Governance Committee · Chair	Filana Therapeutics, Inc.	Not stated
M. Kathleen Behrens, Ph.D. Board chair	73	2009 17 years	Not stated	Audit Committee · Chair	MiMedx Group Inc.	Not stated
Stephen L. Mayo, Ph.D.	64	2021 5 years	Not stated	Audit Committee Research and Development Committee	Merck, Allogene Therapeutics	Not stated
Claude Nicaise, M.D.	73	2015 11 years	Not stated	Compensation Committee Research and Development Committee	Minoryx, Gain Therapeutics, Chemomab, Filana Therapeutics, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 24, 2026

Michael A. Chambers Living Trust

an entity affiliated with Michael Chambers, a member of our Board of Directors

$20.0 million in aggregate principal amount

Privately negotiated exchange of $20.0 million principal of 1.25% Convertible Senior Notes due 2027 for $20.0 million of 4.875% Convertible Senior Notes due 2030 and approximately $2.2 million in cash.

Open in proxy

Comments

Company Executives

$SRPT Management Team

Dr. M. Kathleen Behrens

Mr. Ian Estepan

Mr. Douglas Ingram

Mr. Ryan Wong

Dr. Louise Rodino-Klapac

Ms. Cristin Rothfuss

Mr. Dallan Murray

Board of Directors

Related-party transactions